Featured Articles
Latest News
After being selected as a 2024 Law360 Product Liability MVP, Seeger Weiss co-founder Chris Seeger sat down with the publication to discuss his career journey and his advice to junior attorneys. Seeger found himself entering the product liability world after he “couldn’t connect” with corporate law. His first personal injury case changed everything for him. […]
RIDGEFIELD PARK, NJ – Seeger Weiss is proud to announce that two of its partners, Christopher Seeger and Jennifer Scullion, have been appointed by the Honorable Judge Matthew F. Kennelly of the Northern District of Illinois to leadership positions in the MultiPlan Health Insurance Providers Litigation. Seeger was selected as Plaintiffs’ Coordinating Counsel for the […]
RIDGEFIELD PARK, NJ – Seeger Weiss partner Jennifer Scullion has been appointed as co-chair of the Plaintiff’s Steering Committee for the Provider Track by the Honorable Judge Donovan W. Frank in the Change Healthcare, Inc. Customer Data Security Breach Litigation. The multidistrict litigation centralized in the District of Minnesota consolidates nearly 50 class action lawsuits […]
Seeger Weiss has been honored with the 2024 Regional Powerhouse Award from Law360, recognizing the firm’s pivotal role in shaping the legal landscape in New Jersey and beyond. Known for its leadership in complex litigation and significant contributions to mass torts, environmental law, product liability, and eDiscovery, Seeger Weiss remains dedicated to providing our high […]
Seeger Weiss is proud to announce that six partners — Chris Seeger, Stephen Weiss, David Buchanan, Shauna Itri, Parvin Aminolroaya, and Jennifer Scullion — have been named to the 2025 Lawdragon 500 Leading Litigators in America list. This prestigious guide, first published in 2007, seeks to highlight 500 of the most distinguished litigators in the […]
Seeger Weiss partner Parvin Aminolroaya recently appeared on CBS News to discuss ongoing litigation against pharmaceutical companies Novo Nordisk and Eli Lilly over their popular GLP-1 receptor agonist medications such as Ozempic, Wegovy, Mounjaro, and Zepbound. Our firm represents patients across the country who allege they suffered serious medical complications while taking these drugs and […]